Key facts
- This page summarizes Lisa Ann Rometty's Form 4 filing for Rani Therapeutics Holdings, Inc. (RANI).
- 4 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 17 Dec 2024, 17:00.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Disposed to Issuer
Award
Disposed to Issuer
Award
Additional SEC filing notes
Footnote F1
On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $4.11 per share. There is no change to the expiration dates or the vesting schedule of the options.
Footnote F2
The shares subject to the option vest as follows: 1/3rd of the shares subject to the option vested on January 3, 2023; and 1/36th of the shares subject to the option vest monthly over the following two years.
Footnote F3
On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $17.00 per share. There is no change to the expiration dates or the vesting schedule of the options.